New study highlights impact of sleep disturbances on COVID-19 and long COVID

FHS
July 10, 2024
9:34 am

The influence of pre-existing sleep disturbances on coronavirus disease 2019 (COVID-19) susceptibility, severity, and long-term effects.

4DMT’s gene therapy reduced need for standard-of-care injections to treat age-associated vision loss

4D Molecular Therapeutics’ one-time gene therapy reduced the need for annual injections in patients with age-related blindness in a mid-stage trial. The company on Wednesday

September 20, 2024

Heart Transplant Rejection drugs in development, 2023

GlobalData tracks 8 drugs in development for Heart Transplant Rejection by seven companies/universities/institutes. The top development phase for Heart Transplant Rejection is preclinical, with five

December 1, 2023

M1 Kliniken AG (von First Berlin Equity Research GmbH) – Biotech Investments

Original-Research: M1 Kliniken AG – from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to M1 Kliniken AG Company Name: M1

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.